These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7877821)

  • 21. HRT: some unresolved clinical issues in breast cancer, endometrial cancer and premature ovarian insufficiency.
    Davey DA
    Womens Health (Lond); 2013 Jan; 9(1):59-67. PubMed ID: 23241155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hormone replacement therapy and cancer of the breast. 1. Does replacement therapy increase the risk of cancer of the breast?].
    Ayres de Campos D; Barros H; Martinez de Oliveira J
    Acta Med Port; 1997 Oct; 10(10):697-703. PubMed ID: 9477595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation and management of the hormone replacement therapy (HRT) candidate.
    Hillard T
    Int J Fertil Womens Med; 1997; 42 Suppl 2():347-64. PubMed ID: 9397383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does HRT modify risk of gynecological cancers?
    Schneider HP; Birkhauser M
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():40-53. PubMed ID: 7581588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone replacement therapy (HRT) and endometrial morphology under consideration of the different molecular pathways in endometrial carcinogenesis.
    Horn LC; Dietel M; Einenkel J
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):4-12. PubMed ID: 15927347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmenopausal vaginal bleeding in women using hormone replacement therapy.
    Burbos N; Musonda P; Duncan TJ; Crocker SG; Nieto JJ; Morris EP
    Menopause Int; 2012 Mar; 18(1):5-9. PubMed ID: 22323674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [What's new in hormone replacement therapy of postmenopausal women? II. Risks of hormone replacement therapy (HRT)].
    Martin-Du Pan RC; Luzuy F
    Rev Med Suisse Romande; 2000 Jun; 120(6):523-7. PubMed ID: 11014097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?
    Roy JA; Sawka CA; Pritchard KI
    J Clin Oncol; 1996 Mar; 14(3):997-1006. PubMed ID: 8622051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HRT and cancer risk: separating fact from fiction.
    Schneider HP
    Maturitas; 1999 Nov; 33 Suppl 1():S65-72. PubMed ID: 10661617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmenopausal hormone replacement therapy and major clinical outcomes: a focus on cardiovascular disease, osteoporosis, dementia, and breast and endometrial neoplasia.
    Dick SE; DeWitt DE; Anawalt BD
    Am J Manag Care; 2002 Jan; 8(1):95-104; quiz 105-6. PubMed ID: 11814176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormone replacement therapy and cancer of the breast. 2. Should a woman with cancer of the breast receive hormone replacement therapy?].
    Ayres de Campos D; Cardoso MJ; Martinez de Oliveira J
    Acta Med Port; 1997 Oct; 10(10):705-11. PubMed ID: 9477596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cancer risk under hormone therapy].
    Lauritzen C
    Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen replacement therapy: is previously treated cancer a contraindication?
    Creasman WT
    Obstet Gynecol; 1991 Feb; 77(2):308-12. PubMed ID: 1988899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical issues and hormone replacement therapy.
    Harris PF
    Curr Womens Health Rep; 2002 Oct; 2(5):373-81. PubMed ID: 12215310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated].
    Emons G; Westphalen S
    MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone replacement therapy (HRT) in women after genital cancer.
    Schindler AE
    Maturitas; 2002 Apr; 41 Suppl 1():S105-11. PubMed ID: 11955798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case in point. Counseling about hormone replacement therapy.
    Mahon SM
    Oncol Nurs Forum; 1998 May; 25(4):663-4. PubMed ID: 9599344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone replacement therapy in cancer survivors: Utopia?
    Angioli R; Luvero D; Armento G; Capriglione S; Plotti F; Scaletta G; Lopez S; Montera R; Gatti A; Serra GB; Benedetti Panici P; Terranova C
    Crit Rev Oncol Hematol; 2018 Apr; 124():51-60. PubMed ID: 29548486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.